86 related articles for article (PubMed ID: 38629748)
1. Emerging Strategies in Mesenchymal Stem Cell-Based Cardiovascular Therapeutics.
Kumar R; Mishra N; Tran T; Kumar M; Vijayaraghavalu S; Gurusamy N
Cells; 2024 May; 13(10):. PubMed ID: 38786076
[TBL] [Abstract][Full Text] [Related]
2. Mechanism Exploration on the Immunoregulation of Allogeneic Heart Transplantation Rejection in Rats With Exosome miRNA and Proteins From Overexpressed IDO1 BMSCs.
Zheng R; Wu X; Li S; Chen X; Yan D; He J
Cell Transplant; 2024; 33():9636897241245796. PubMed ID: 38629748
[TBL] [Abstract][Full Text] [Related]
3. The effects of exosomes originating from different cell sources on the differentiation of bone marrow mesenchymal stem cells into schwann cells.
Zhang X; Zhang W; Sun H; Wang H
J Nanobiotechnology; 2024 May; 22(1):220. PubMed ID: 38698449
[TBL] [Abstract][Full Text] [Related]
4. Impaired immunosuppressive effect of bone marrow mesenchymal stem cell-derived exosomes on T cells in aplastic anemia.
Wang S; Huo J; Liu Y; Chen L; Ren X; Li X; Wang M; Jin P; Huang J; Nie N; Zhang J; Shao Y; Ge M; Zheng Y
Stem Cell Res Ther; 2023 Oct; 14(1):285. PubMed ID: 37794484
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow mesenchymal stem cell-derived exosomes attenuate the maturation of dendritic cells and reduce the rejection of allogeneic transplantation.
Sang H; Zhao R; Lai G; Deng Z; Zhuang W; Wu M; Wu J
Adv Clin Exp Med; 2023 May; 32(5):551-561. PubMed ID: 36881365
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow stromal cells-derived exosomes reduce neurological damage in traumatic brain injury through the miR-124-3p/p38 MAPK/GLT-1 axis.
Zhuang Z; Liu M; Dai Z; Luo J; Zhang B; Yu H; Xue J; Xu H
Exp Neurol; 2023 Jul; 365():114408. PubMed ID: 37061176
[TBL] [Abstract][Full Text] [Related]
7. Exosomes derived from miRNA-210 overexpressing bone marrow mesenchymal stem cells protect lipopolysaccharide induced chondrocytes injury via the NF-κB pathway.
He L; Chen Y; Ke Z; Pang M; Yang B; Feng F; Wu Z; Liu C; Liu B; Zheng X; Wu T; Shu T
Gene; 2020 Aug; 751():144764. PubMed ID: 32428694
[TBL] [Abstract][Full Text] [Related]
8. Indoleamine 2,3-Dioxygenase 1 (IDO1) in Kidney Transplantation: A Guardian against Rejection.
Wiśnicki K; Donizy P; Hałoń A; Wawrzonkowski P; Janczak D; Krajewska M; Banasik M
J Clin Med; 2023 Dec; 12(24):. PubMed ID: 38137602
[TBL] [Abstract][Full Text] [Related]
9. Investigating the prognostic role of lncRNAs associated with disulfidptosis-related genes in clear cell renal cell carcinoma.
Sun Z; Wang J; Fan Z; Yang Y; Meng X; Ma Z; Niu J; Guo R; Tran LJ; Zhang J; Jiang T; Liu Y; Yang Q; Ma B
J Gene Med; 2024 Jan; 26(1):e3608. PubMed ID: 37897262
[TBL] [Abstract][Full Text] [Related]
10. Unveiling the key genes, environmental toxins, and drug exposures in modulating the severity of ulcerative colitis: a comprehensive analysis.
Wang Y; Zhuang H; Jiang XH; Zou RH; Wang HY; Fan ZN
Front Immunol; 2023; 14():1162458. PubMed ID: 37539055
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-IL-10 relieves chronic rejection after mouse heart transplantation by inhibiting miR-155 and activating SOCS5.
Kong G; Chen Y; Liu Z; Wang Y; Li H; Guo C
Int J Med Sci; 2023; 20(2):172-185. PubMed ID: 36794154
[No Abstract] [Full Text] [Related]
12. Significance of Indoleamine 2,3-Dioxygenase Expression in the Immunological Response of Kidney Graft Recipients.
Wiśnicki K; Donizy P; Remiorz A; Janczak D; Krajewska M; Banasik M
Diagnostics (Basel); 2022 Sep; 12(10):. PubMed ID: 36292041
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]